References
- Asín MAPJ, Fernández-Ruiz M, López-Medrano F, et al. Bacillus Calmette-Guérin (BCG) infection following intravesical bcg administration as adjunctive therapy for bladder cancer incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine. 2014;93(17):236–254.
- Soylu A, Ince AT, Polat H, et al. Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin. Ann Clin Microbiol Antimicrob. 2009;8:12.
- Iqbal J, Raja M, Leung J. Peritoneal tuberculosis presenting as recurrent peritonitis secondary to treatment with intravesical Bacillus Calmette-Guérin in a patient receiving peritoneal dialysis. Clin Kidney J. 2015;8(1):107–108.
- Ströck V, Dotevall L, Sandberg T, et al. Late bacille Calmette–Guérin infection with a large focal urinary bladder ulceration as a complication of bladder cancer treatment. BJU Int. 2011;107(10):1592–1597.